Wake promoting agents: search for next generation modafinil, lessons learned: part III

Area of Science:

• Medicinal Chemistry
• Neuroscience
• Pharmacology

Background:

• Modafinil is a novel wake-promoting agent.
• There is a need for next-generation molecules with improved efficacy or pharmacokinetic profiles.
• Fluorene derivatives represent a potential scaffold for developing novel CNS stimulants.

Purpose of the Study:

• To synthesize and evaluate a series of fluorene-derived compounds as potential wakefulness-enhancing agents.
• To identify novel analogs with improved properties compared to existing agents like modafinil.

Main Methods:

• Synthesis of a series of fluorene-derived compounds.
• In vivo evaluation of wakefulness-promoting activity in rat models.
• Pharmacokinetic studies of potent compounds, including metabolite identification.

Main Results:

• Several fluorene-derived compounds demonstrated significant wakefulness-enhancing activity in rats.
• Compound 15, a potent analog, underwent extensive pharmacokinetic evaluation.
• The wake promotion activity of compound 15 was attributed to its active metabolite, compound 3.

Conclusions:

• Fluorene derivatives are a promising class of compounds for developing novel wakefulness-promoting agents.
• Metabolite profiling is crucial for understanding the in vivo activity of drug candidates.
• Compound 3 represents a potential lead for future development of next-generation wakefulness-promoting medications.